A carregar...
Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation
Non-valvular atrial fibrillation is becoming more common in Australia and globally The direct oral anticoagulants apixaban, dabigatran and rivaroxaban offer an improved safety profile over warfarin Patient preferences are important and shared decision-making supports better adherence to treatment
Na minha lista:
| Publicado no: | Aust Prescr |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
NPS MedicineWise
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8075749/ https://ncbi.nlm.nih.gov/pubmed/33911332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18773/austprescr.2021.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|